Oculogyric crisis

Signs and symptoms

Initial symptoms include restlessness, agitation, malaise, or a fixed stare. Then comes the more characteristically described extreme and sustained upward deviation of the eyes. In addition, the eyes may converge, deviate upward and laterally, or deviate downward. The most frequently reported associated findings are backwards and lateral flexion of the neck, widely opened mouth, tongue protrusion, and ocular pain. However, the condition may also be associated with intensely painful jaw spasms which may result in the breaking of a tooth. A wave of exhaustion may follow an episode. The abrupt termination of the psychiatric symptoms at the conclusion of the crisis is most striking.

Other features that are noted during attacks include mutism, palilalia, eye blinking, lacrimation, pupil dilation, drooling, respiratory dyskinesia, increased blood pressure and heart rate, facial flushing, headache, vertigo, anxiety, agitation, compulsive thinking, paranoia, depression, recurrent fixed ideas, depersonalization, violence, and obscene language.

In addition to the acute presentation, oculogyric crisis can develop as a recurrent syndrome, triggered by stress and by exposure to the drugs mentioned below.

Causes

Drugs that can trigger an oculogyric crisis include neuroleptics (such as haloperidol, chlorpromazine, fluphenazine, olanzapine), carbamazepine, chloroquine, cisplatin, diazoxide, levodopa, lithium, metoclopramide, lurasidone, domperidone, nifedipine, pemoline, phencyclidine ("PCP"), reserpine, and cetirizine, an antihistamine. High-potency neuroleptics are the most common cause.

Other causes can include aromatic L-amino acid decarboxylase deficiency, postencephalitic Parkinson's, Tourette's syndrome, multiple sclerosis, neurosyphilis, head trauma, bilateral thalamic infarction, lesions of the fourth ventricle, cystic glioma of the third ventricle, herpes encephalitis, kernicterus and juvenile Parkinson's disease.

Diagnosis

The diagnosis of oculogyric crisis is largely clinical and involves taking a focused history and physical examination to identify possible triggers for the crisis and rule out other causes of abnormal ocular movements.

Treatment

Immediate treatment of drug-induced OGC can be achieved with intravenous antimuscarinics, such as benzatropine or procyclidine. Any causative new medication should be discontinued. The condition may also be treated with the antihistamine diphenhydramine.

References

References

1. (March 2014). "Oculogyric crisis in a patient taking metoclopramide". Clinical Ophthalmology.
2. (2017). "Oculogyric crises: Etiology, pathophysiology and therapeutic approaches". Parkinsonism & Related Disorders.
3. (2009). "Epilepsy A to Z: A Concise Encyclopedia". Demos Medical Publishing.
4. (March 2017). "Oculogyric crises: Etiology, pathophysiology and therapeutic approaches". Pakinsonism and Related Disorders.
5. (March 2017). "Oculogyric crises: Etiology, pathophysiology and therapeutic approaches". Pakinsonism and Related Disorders.
6. (December 2009). "Olanzapine-Induced Tardive Oculogyric Crisis". Journal of Clinical Psychopharmacology.
7. (February 2014). "Oculogyric crises induced by levodopa in PLA2G6 parkinsonism-dystonia". Parkinsonism & Related Disorders.
8. (2015). "Phencyclidine Induced Oculogyric Crisis Responding Well to Conventional Treatment". Case Reports in Emergency Medicine.
9. (January 1997). "Aromatic l-amino acid decarboxylase deficiency: An extrapyramidal movement disorder with oculogyric crises". European Journal of Paediatric Neurology.
10. (March 2017). "Oculogyric crises: Etiology, pathophysiology and therapeutic approaches". Pakinsonism and Related Disorders.
11. (2010). "Neuro-Ophthalmology".